Advertisement
Advertisement

BMEA

BMEA logo

Biomea Fusion, Inc. Common Stock

1.93
USD
Sponsored
+0.13
+6.94%
Sep 02, 15:15 UTC -4
Open

Biomea Fusion, Inc. Common Stock Profile

About

Biomea Fusion Inc. is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecules, icovamenib and BMF-650. Biomea Fusion Inc., formerly known as BLOMEA FUSION, is based in Redwood City, California.

Info & Links

CEO

Michael J.M. Hitchcock

Headquarters

1599 INDUSTRIAL ROAD
SAN CARLOS, CA 94070, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.biomeafusion.com

Auditor

Deloitte & Touche LLP

Share holders

29

Employees

41

Biomea Fusion, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

139.53M

Enterprise Value

105.22M

Enterprise Value/EBITDA(ttm)

-1.83

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

10.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-253.73%

Return on Invested Capital(ttm)

-224.38%

Return on Assets(ttm)

-97.91%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-57.52M

Net Income Available to Common(ttm)

-32.54M

Diluted EPS(ttm)

-0.29

Share Statistics

Beta (5Y Monthly)

-0.23

52-Week Change

-1.28%

S&P 500 52-Week Change

18.85%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

72.48M

Dividend Yield

0.00%

Float4

64.80M

% Held by Insiders

10.60%

% Held by Institutions

96.72%

Balance Sheet

Total Cash(mrq)

35.19M

Total Cash Per Share(mrq)

0.49

Total Debt(mrq)

877.00K

Total Debt/Equity(mrq)

7.23%

Current Ratio(mrq)

3.48%

Quick Ratio(mrq)

3.47%

Book Value Per Share(mrq)

0.17

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.30

Free Cash Flow(ytd)

-21.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement